Agilent Technologies and BioNanomatrix will collaborate on developing a new genetic analysis system. The system will foster the development of life-sciences applications like assays for genotoxicity and cytogenetics as well as DNA sequencing, according to Michael Boyce-Jacino, CEO of BioNanomatrix. Agilent will develop the measurement instrumentation platform for the system, which will use BioNanomatrix's nanoscale single-molecule imaging technology to develop chips and reagents. BioNanomatrix develops nanoscale genome imaging platforms, providing high-resolution analyses of DNA. The two companies intend to collaborate closely in the development of an integrated system and applications, according to Nick Roelofs, vice president and general manager of the Life Sciences Solutions Unit at Agilent.
Comments